Clinical Trials

Showing trials with last updates posted in 2022.

NCT03709550 | WITHDRAWN | PHASE1/PHASE2
0 participants

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2022-10-05
Start Date:
2021-04-15
Completion:
2023-04-15
Conditions
  • Castration Levels of Testosterone
  • Castration-Resistant Prostate Carcinoma
  • Metastatic Prostate Carcinoma in the Soft Tissue
  • Prostate Carcinoma Metastatic in the Bone
  • PSA Level Greater Than or Equal to Two
  • PSA Progression
  • Stage IV Prostate Cancer AJCC v8
  • Stage IVA Prostate Cancer AJCC v8
  • Stage IVB Prostate Cancer AJCC v8
Interventions
  • DRUG
No Results Yet
NCT03441360 | COMPLETED | PHASE2
23 participants

Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)

Study Type:
INTERVENTIONAL
Last Updated:
2022-10-05
Start Date:
2018-04-17
Completion:
2021-01-07
Conditions
  • Relapsed/Refractory Rhabdomyosarcoma
  • Non-rhabdomyosarcoma Soft Tissue Sarcoma
  • Ewing Sarcoma
Interventions
  • DRUG
NCT00053157 | COMPLETED | NA
10 participants

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

Study Type:
INTERVENTIONAL
Last Updated:
2022-10-05
Start Date:
2002-06-30
Completion:
2004-08-31
Conditions
  • Chronic Myeloproliferative Disorders
  • Graft Versus Host Disease
  • Leukemia
  • Lymphoma
  • Myelodysplastic Syndromes
  • Myelodysplastic/Myeloproliferative Neoplasms
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page